A Bioinorganic Approach to Fragment-Based Drug Discovery Targeting Metalloenzymes

Accounts of Chemical Research

Volumn 50, Issue 8, 2017, Pages 2007-2016

  Cohen, Seth M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME; METALLOPROTEIN;

CHEMISTRY; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG DEVELOPMENT;

DRUG DELIVERY SYSTEMS; DRUG DESIGN; DRUG DISCOVERY; ENZYMES; METALLOPROTEINS;

EID: 85027461797     PISSN: 00014842     EISSN: 15204898     Source Type: Journal    
DOI: 10.1021/acs.accounts.7b00242     Document Type: Article

References (38)

1. Yang, Y.; Hu, X.-Q.; Li, Q.-S.; Zhang, X.-X.; Ruan, B.-F.; Xu, J.; Liao, C. Metalloprotein Inhibitors for the Treatment of Human Diseases Curr. Top. Med. Chem. 2016, 16, 384-396 10.2174/1568026615666150813145218
2. Martin, D. P.; Puerta, D. T.; Cohen, S. M. Metalloprotein Inhibitors. In Ligand Design in Medicinal Inorganic Chemistry; Storr, T., Ed.; John Wiley & Sons, Ltd: United Kingdom, 2014; pp 375-404.
3. Whittaker, M.; Floyd, C. D.; Brown, P.; Gearing, A. J. H. Design and therapeutic application of matrix metalloproteinase inhibitors Chem. Rev. 1999, 99, 2735-2776 10.1021/cr9804543
4. Johnstone, T. C.; Nolan, E. M. Beyond Iron: Non-classical Biological Functions of Bacterial Siderophores Dalton Trans. 2015, 44, 6320-6339 10.1039/C4DT03559C
5. Hajduk, P. J.; Sheppard, G.; Nettesheim, D. G.; Olejniczak, E. T.; Shuker, S. B.; Meadows, R. P.; Steinman, D. H.; Carrera, G. M., Jr.; Marcotte, P. A.; Severin, J.; Walter, K.; Smith, H.; Gubbins, E.; Simmer, R.; Holzman, T. F.; Morgan, D. W.; Davidsen, S. K.; Summers, J. B.; Fesik, S. W. Discovery of potent nonpeptide inhibitors of stromelysin using SAR by NMR J. Am. Chem. Soc. 1997, 119, 5818-5827 10.1021/ja9702778
6. Puerta, D. T.; Lewis, J. A.; Cohen, S. M. New beginnings for matrix metalloproteinase inhibitors: identification of high-affinity zinc-binding groups J. Am. Chem. Soc. 2004, 126, 8388-8389 10.1021/ja0485513
7. Congreve, M.; Chessari, G.; Tisi, D.; Woodhead, A. J. Recent developments in fragment-based drug discovery J. Med. Chem. 2008, 51, 3661-3680 10.1021/jm8000373
8. Erlanson, D. A.; Fesik, S. W.; Hubbard, R. E.; Jahnke, W.; Jhoti, H. Twenty Years On: The Impact of Fragments on Drug Discovery Nat. Rev. Drug Discovery 2016, 15, 605-619 10.1038/nrd.2016.109
9. Puerta, D. T.; Mongan, J.; Tran, B. L.; McCammon, J. A.; Cohen, S. M. Potent, selective pyrone-based inhibitors of stromelysin-1 J. Am. Chem. Soc. 2005, 127, 14148-14149 10.1021/ja054558o
10. Jacobsen, F. E.; Lewis, J. A.; Cohen, S. M. A new role for old ligands: discerning chelators for zinc metalloproteinases J. Am. Chem. Soc. 2006, 128, 3156-3157 10.1021/ja057957s
11. Rouffet, M.; de Oliveira, C. A. F.; Udi, Y.; Agrawal, A.; Sagi, I.; McCammon, J. A.; Cohen, S. M. From Sensors to Silencers: Quinoline- and Benzimidazole-Sulfonamides as Inhibitors for Zinc Proteases J. Am. Chem. Soc. 2010, 132, 8232-8233 10.1021/ja101088j
12. Lipinski, C. A.; Lombardo, F.; Dominy, B. W.; Feeney, P. J. Experimental and Computational Approaches to Estimate Solubility and Permeability in Drug Discovery and Development Settings Adv. Drug Delivery Rev. 2001, 46, 3-26 10.1016/S0169-409X(00)00129-0
13. Congreve, M.; Carr, R.; Murray, C.; Jhoti, H. A 'Rule of Three' for Fragment-based Lead Discovery Drug Discovery Today 2003, 8, 876-877 10.1016/S1359-6446(03)02831-9
14. Hajduk, P. J.; Shuker, S. B.; Nettesheim, D. G.; Craig, R.; Augeri, D. J.; Betebenner, D.; Albert, D. H.; Guo, Y.; Meadows, R. P.; Xu, L.; Michaelides, M.; Davidsen, S. K.; Fesik, S. W. NMR-Based Modification of Matrix Metalloproteinase Inhibitors with Improved Bioavailability J. Med. Chem. 2002, 45, 5628-5639 10.1021/jm020160g
15. Vahrenkamp, H. Transitions, Transition States, Transition State Analogues: Zinc Pyrazolylborate Chemistry Related to Zinc Enzymes Acc. Chem. Res. 1999, 32, 589-596 10.1021/ar9703185
16. Puerta, D. T.; Cohen, S. M. Elucidating Drug-Metalloprotein Interactions with Tris(pyrazolyl)borate Model Complexes Inorg. Chem. 2002, 41, 5075-5082 10.1021/ic0204272
17. Puerta, D. T.; Schames, J. R.; Henchman, R. H.; McCammon, J. A.; Cohen, S. M. From Model Complexes to Metalloprotein Inhibition: A Synergistic Approach to Structure-based Drug Discovery Angew. Chem., Int. Ed. 2003, 42, 3772-3774 10.1002/anie.200351433
18. Silverman, R. B. The Organic Chemistry of Drug Design and Drug Action, 2 nd ed.; Elsevier Academic Press: London, 2012.
19. Agrawal, A.; Johnson, S. L.; Jacobsen, J. A.; Miller, M. T.; Chen, L.-H.; Pellecchia, M.; Cohen, S. M. Chelator fragment libraries for targeting metalloproteinases ChemMedChem 2010, 5, 195-199 10.1002/cmdc.200900516
20. Jacobsen, J. A.; Fullagar, J. L.; Miller, M. T.; Cohen, S. M. Identifying Chelators for Metalloprotein Inhibitors Using a Fragment-Based Approach J. Med. Chem. 2011, 54, 591-602 10.1021/jm101266s
21. Fullagar, J. L.; Garner, A. L.; Struss, A. K.; Day, J. A.; Martin, D. P.; Yu, J.; Cai, X. Q.; Janda, K. D.; Cohen, S. M. Antagonism of a Zinc Metalloprotease Using a Unique Metal-Chelating Scaffold: Tropolones as Inhibitors of P. aeruginosa Elastase Chem. Commun. 2013, 49, 3197-3199 10.1039/c3cc41191e
22. Perez, C.; Li, J.; Parlati, F.; Rouffet, M.; Ma, Y.; Mackinnon, A. L.; Chou, T.-F.; Deshaies, R. J.; Cohen, S. M. Discovery of an Inhibitor of the Proteasome Subunit Rpn11 J. Med. Chem. 2017, 60, 1343-1361 10.1021/acs.jmedchem.6b01379
23. Crawford, L. J.; Walker, B.; Irvine, A. E. Proteasome Inhibitors in Cancer Therapy J. Cell Commun. Signal 2011, 5, 101-110 10.1007/s12079-011-0121-7
24. Gallastegui, N.; Groll, M. The 26S proteasome: Assembly and Function of a Destructive Machine Trends Biochem. Sci. 2010, 35, 634-642 10.1016/j.tibs.2010.05.005
25. Ambroggio, X. I.; Rees, D. C.; Deshaies, R. J. JAMM: A Metalloprotease-like Zinc Site in the Proteasome and Signalosome PLoS Biol. 2003, 2, e2 10.1371/journal.pbio.0020002
26. Verma, R.; Aravind, L.; Oania, R.; McDonald, W. H.; Yates, J. R.; Koonin, E. V.; Deshaies, R. J. Role of Rpn11 Metalloprotease in Deubiquitination and Degradation by the 26S Proteasome Science 2002, 298, 611-615 10.1126/science.1075898
27. Li, J.; Yakushi, T.; Parlati, F.; Mackinnon, A. L.; Perez, C.; Ma, Y.; Carter, K. P.; Colayco, S.; Magnuson, G.; Brown, B.; Nguyen, K.; Vasile, S.; Suyama, E.; Smith, L. H.; Sergienko, E.; Pinkerton, A. B.; Chung, T. D. Y.; Palmer, A. E.; Pass, I.; Hess, S.; Cohen, S. M.; Deshaies, R. J. Capzimin is a Potent and Specific Inhibitor of Proteasome Isopeptidase Rpn11 Nat. Chem. Biol. 2017, 13, 486-493 10.1038/nchembio.2326
28. Day, J. A.; Cohen, S. M. Investigating the Selectivity of Metalloenzyme Inhibitors J. Med. Chem. 2013, 56, 7997-8007 10.1021/jm401053m
29. Chen, Y.; Cohen, S. M. Investigating the Selectivity of Metalloenzyme Inhibitors in the Presence of Competing Metalloproteins ChemMedChem 2015, 10, 1733-1738 10.1002/cmdc.201500293
30. Chen, Y.; Lai, B.; Zhang, Z.; Cohen, S. M. The Effect of Metalloprotein Inhibitors on Cellular Metal Ion Content and Distribution Metallomics 2017, 9, 250-257 10.1039/C6MT00267F
31. Martin, D. P.; Hann, Z. S.; Cohen, S. M. Metalloprotein-Inhibitor Binding: Human Carbonic Anhydrase II as a Model for Probing Metal-Ligand Interactions in a Metalloprotein Active Site Inorg. Chem. 2013, 52, 12207-12215 10.1021/ic400295f
32. Dick, B. L.; Patel, A.; McCammon, J. A.; Cohen, S. M. Effect of donor atom identity on metal-binding pharmacophore coordination JBIC, J. Biol. Inorg. Chem. 2017, 22, 605-613 10.1007/s00775-017-1454-3
33. Martin, D. P.; Blachly, P. G.; McCammon, J. A.; Cohen, S. M. Exploring the Influence of the Protein Environment on Metal-Binding Pharmacophores J. Med. Chem. 2014, 57, 7126-7135 10.1021/jm500984b
34. Martin, D. P.; Blachly, P. G.; Marts, A. R.; Woodruff, T. M.; deOliveira, C. A. F.; McCammon, J. A.; Tierney, D. L.; Cohen, S. M. Unconventional' Coordination Chemistry by Metal Chelating Fragments in a Metalloprotein Active Site J. Am. Chem. Soc. 2014, 136, 5400-5406 10.1021/ja500616m
35. Bauman, J. D.; Patel, D.; Baker, S. F.; Vijayan, R. S.; Xiang, A.; Parhi, A. K.; Martinez-Sobrido, L.; LaVoie, E. J.; Das, K.; Arnold, E. Crystallographic fragment screening and structure-based optimization yields a new class of influenza endonuclease inhibitors ACS Chem. Biol. 2013, 8, 2501-2508 10.1021/cb400400j
36. Luo, Q. L.; Li, J. Y.; Liu, Z. Y.; Chen, L. L.; Li, J.; Qian, Z.; Shen, Q.; Li, Y.; Lushington, G. H.; Ye, Q. Z.; Nan, F. J. Discovery and structural modification of inhibitors of methionine aminopeptidases from Escherichia coli and Saccharomyces cerevisiae J. Med. Chem. 2003, 46, 2631-2640 10.1021/jm0300532
37. Patil, V.; Sodji, Q. H.; Kornacki, J. R.; Mrksich, M.; Oyelere, A. K. 3-Hydroxypyridin-2-thione as novel zinc binding group for selective histone deacetylase inhibition J. Med. Chem. 2013, 56, 3492-3506 10.1021/jm301769u
38. Chiba, T.; Ohwada, J.; Sakamoto, H.; Kobayashi, T.; Fukami, T. A.; Irie, M.; Miura, T.; Ohara, K.; Koyano, H. Design and evaluation of azaindole-substituted N-hydroxypyridones as glyoxalase I inhibitors Bioorg. Med. Chem. Lett. 2012, 22, 7486-7489 10.1016/j.bmcl.2012.10.045